Vernalis (VER)

 

VER Share PerformanceMore

52 week high39.335 02/11/16
52 week low10.000 12/10/17
52 week change -25.250 (-66.01%)
4 week volume7,744,858 25/09/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Block listing Interim Review

RNS Number: 8539R Vernalis PLC 29 September 2017 BLOCK LISTING SIX MONTHLY RETURN AND BLOCK LISTING APPLICATION VERNALIS PLC (the "Company") 29 September 2017 Vernalis plc (LSE: VER) provides the following update in accordance with Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements...

Vernalis sales beat market expectations

Vernalis reported revenue of 20.8m (2016: 12m), which was ahead of market expectations in the year to 30 June 2017. US CO...

Results Announcement for the Year Ended 30/06/2017

RNS Number: 4293Q Vernalis PLC 12 September 2017 12 September 2017 LSE: VER Vernalis plc Results Announcement for the year ended 30 June 2017 Tuzistra XR prescriptions growing steadily In-house salesforce to promote both Tuzistra XR and Moxatag for the coming season Independent market research continues to show significant market opportunity for co...

FDA Issues Complete Response Letter on CCP-08 NDA

RNS Number: 2148N Vernalis PLC 07 August 2017 07 August 2017 LSE: VER FDA Issues a Complete Response Letter on CCP-08 NDA Vernalis plc announced today that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for CCP-08. A CRL is issued by the FDA when it has comple...

Broker Forecast - Cantor Fitzgerald issues a broker note on Vernalis PLC

Cantor Fitzgerald today reaffirms its buy investment rating on Vernalis PLC (LON:VER) and cut its price target to 81p (fr...

Vernalis anticipates sales to be expectations

Vernalis said total revenues are expected to be ahead of current market expectations. This was principally as a result of lar...

Year-End Trading Update and Notice of Results

RNS Number: 2825L Vernalis PLC 18 July 2017 18 July 2017 LSE: VER Year-End Trading Update and Notice of Full Year Results Continued steady growth of Tuzistra XR annualised prescription run rate through drug's second cough cold season; similar growth rate expected for 2017/18 season Plan to resume full promotion of Moxatag in September Continued to adv...

Total Voting Rights

RNS Number: 6343J Vernalis PLC 30 June 2017 TOTAL VOTING RIGHTS VERNALIS PLC (the "Company") 30 June 2017 Vernalis plc (LSE: VER) announces that the Company's total issued share capital at the date of this announcement is 526,445,230 ordinary shares of 1p each, with one voting right per share. There are no shares held in treasury. The total number o...

Fundamental DataMore

EPS-4.1
Dividend yield0 %

Latest discussion posts More

  • Re: Perfect short this one !

    Remember my post back in April ? Not many here since . Chart don't lie , it didn't then it isn't now . Though it may be basing . Or about to . In other words we ...
    17-Aug-2017
    onedb1
  • Bearish despite RNS

    Recent RNS from Vernalis: "Total revenues are expected to be ahead of current market expectations, principally as a result of larger than expected research collaboration ...
    2-Aug-2017
    optimusanimus
  • Perfect short this one !

    Just need to time the close now ! Lurking on these beautiful trending stocks you can bet is where you can find me ! Its all I look out for 24/7 !! Just need the time to ...
    28-Apr-2017
    onedb1

Users' HoldingsMore

Users who hold Vernalis also hold..
LLOYDS GRP.34%
VODAFONE GRP.19%
BT GROUP19%
GLAXOSMITHKLINE18%
BP17%

Codes & Symbols

ISINGB00B3Y5L754
SymbolsVER, LSE:VER, VER.L, VER:LN, LON:VER, XLON:VER